Original language | English (US) |
---|---|
Pages (from-to) | 1022-1023 |
Number of pages | 2 |
Journal | The Lancet Oncology |
Volume | 17 |
Issue number | 8 |
DOIs |
|
State | Published - Aug 1 2016 |
Fingerprint
ASJC Scopus subject areas
- Oncology
Cite this
The case for informative phase 2 trials in osteosarcoma. / Janeway, Katherine A.; Gorlick, Richard.
In: The Lancet Oncology, Vol. 17, No. 8, 01.08.2016, p. 1022-1023.Research output: Contribution to journal › Comment/debate
}
TY - JOUR
T1 - The case for informative phase 2 trials in osteosarcoma
AU - Janeway, Katherine A.
AU - Gorlick, Richard
PY - 2016/8/1
Y1 - 2016/8/1
UR - http://www.scopus.com/inward/record.url?scp=84995933315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995933315&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(16)30293-5
DO - 10.1016/S1470-2045(16)30293-5
M3 - Comment/debate
AN - SCOPUS:84995933315
VL - 17
SP - 1022
EP - 1023
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 8
ER -